-
Steel Partners said to offer $18 per share for 51% of InMode - Bloomberg
-
BTIG keeps InMode (INMD) at Neutral following acquisition rumors
-
InMode expects Q4 2025 revenue of $103.6M-$103.8M, sets earnings date
-
InMode Ltd. (INMD) Tops Q4 EPS by 2c ; Offers Guidance
-
InMode Ltd. (INMD) PT Raised to $16 at Canaccord Genuity
-
Needham Reiterates Hold Rating on InMode Ltd. (INMD)
-
InMode expects Q3 revenue of $92.5M-$93M, maintains 2025 guidance
-
DOMA Perpetual urges InMode board to execute share buybacks
-
InMode Ltd. (INMD) Tops Q3 EPS by 6c, provides guidance
-
BTIG on InMode Ltd. (INMD): 'we think the guidance revision was an appropriate step'
-
InMode Ltd. (INMD) Response Letter to DOMA by Moshe Mizrahy, CEO, Dated May 28, 2025
-
DOMA Perpetual Sends Letter Urging Board of Directors of InMode (INMD) to Resume Share Buyback
-
InMode Ltd. (INMD) Granted Injunction Against Counterfeit Sales of Morpheus8 Radio Frequency Microneedling Devices and Needle Cartridges
-
InMode Ltd. (INMD) PT Lowered to $15 at Canaccord Genuity
-
BTIG Downgrades InMode Ltd. (INMD) to Neutral
-
InMode Ltd. (INMD) Misses Q2 EPS by 7c, provides guidance
-
Canaccord Genuity Reiterates Hold Rating on InMode Ltd. (INMD)
-
Jefferies Maintains InMode Ltd. (INMD) at Hold, Lowers PT, '1Q Prelims Below Cons; FY25 Guide Reiterated But Requires Step-Up; Hold'
-
InMode Ltd. (INMD) Responds to Doma Perpetual's Letters
-
InMode Ltd. (INMD) Misses Q1 EPS by 17c, provides guidance
-
InMode Ltd. (INMD) Reports Q4, Announces Share Buyback
-
DOMA Perpetual Sends Letter Urging Board of Directors of InMode Ltd (INMD) to Immediately Execute Tender Offer followed by Share Buyback
-
Canaccord Genuity Reiterates Hold Rating on InMode Ltd. (INMD)
-
Needham Reiterates Hold Rating on InMode Ltd. (INMD)
-
InMode Ltd. (INMD) Tops Q4 EPS by 9c ; Offers Guidance
-
InMode Ltd. (INMD) Granted Preliminary Injunction Against Online Sellers Prohibiting Counterfeit Sales of Morpheus8 Radiofrequency Devices and Cartridge Accessories
-
BTIG Starts InMode Ltd. (INMD) at Buy
-
Baird Reiterates Outperform Rating on InMode Ltd. (INMD)
-
Canaccord Genuity Reiterates Hold Rating on InMode Ltd. (INMD)
-
Needham Reiterates Hold Rating on InMode Ltd. (INMD)
-
InMode Ltd. (INMD) October 15 calls, November 14 puts, October 14 puts and November 15 puts active as share price down 8%
-
Canaccord Genuity Reiterates Hold Rating on InMode Ltd. (INMD)
-
InMode Ltd. (INMD) Announces Departures of President of North America, Chief Medical Officer and VP of Sales USA
-
InMode Ltd. (INMD) call put ratio 3.5 calls to 1 put as share price up 9%
-
InMode Ltd. (INMD) Announces 7.68M Share Buyback
-
InMode Ltd. (INMD) Misses Q3 EPS by 4c, provides guidance
-
DOMA Perpetual Sends Letter to the Board of Directors of InMode (INMD) Urging the Execution of a 40% Tender Offer
-
Jefferies Downgrades InMode Ltd. (INMD) to Hold
-
InMode Ltd. (INMD): Morpheus8 Secures First and Only FDA Clearance for Soft Tissue Contraction for Fractional Radiofrequency Microneedling
-
InMode Ltd. (INMD) PT Lowered to $21 at Jefferies
-
InMode Ltd. (INMD) PT Lowered to $16 at Canaccord Genuity

